releases: https://www.cramer.senate.gov/sen-cramer-meets-juvenile-diabetes-research-foundation-members-receives-gold-insulin-vials
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://www.cramer.senate.gov/sen-cramer-meets-juvenile-diabetes-research-foundation-members-receives-gold-insulin-vials | Sen. Cramer Meets with Juvenile Diabetes Research Foundation Members, Receives Gold Insulin Vials to Highlight the High Cost of Insulin | 2019-12-26 | 2019 | 2019-12 | Republican | House | ND | Kevin Cramer | C001096 | www.cramer.senate.gov | legacy | ***Click here for audio.*** FARGO Today, U.S. Senator Kevin Cramer (R-ND) met with members of the Juvenile Diabetes Research Foundation (JDRF) to hear their stories. He was presented with Gold Insulin Vials to raise awareness for the rising cost of this life-saving drug byJDRF 2019 North Dakota Delegate for Children's Congress Danika Johnsonand several young people with diabetes who rely on insulin. For these young people and many others, insulin is not an option; it is a necessity,said Senator Cramer.Thank you to them and their families for sharing their stories and for discussing the progress we've made together. I encourage them to stay involved with similar groups and continue working on this important issue. TheGold Vial Projectis a social media campaign which uses gold vials to highlight the rising cost of insulin. They use the slogan, "insulin is worth its weight in gold, but should not cost as much." As the JDRF North Dakota 2019 Children's Congress Delegate, Danika traveled to Washington in July andmet with Senator Cramerto discuss ways to ensure access to quality, affordable health care. In theappropriations package passed last week, Congress included multiple bills led by Senator Cramer to address the high price of insulin, such as the Protecting Access to Biosimilars Act and the Affordable Insulin Approvals Now Act. Congress also provided $150 million for theSpecial Diabetes Program, which Senator Cramer offered his support for in June. Increasing the amount of generic and low-cost insulin in the market will decrease the burden placed on patients who rely on these drugs,Senator Cramersaid last week.I am pleased to see our bipartisan bill included in this package, and I plan to keep working to find more ways to encourage competition and free market solutions to the rising cost of health care." ### | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |